Finance

Beta
Lists
XERS:NASDAQ
Xeris Biopharma Holdings Inc
$6.16
-2.53%
(-0.16) 1D
$6.15
-0.14% (-0.0084)
After hours
Closed: May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XERS...
Open
$6.37
High
$6.37
Low
$6.02
Mkt. cap
1.06B
Avg. vol.
1.59M
Volume
1.94M
P/E ratio
111.07
52-wk high
$10.08
52-wk low
$4.30
EPS
$0.06
Beta
0.79
Shares outstanding
172.64M
No. of employees
435
Open
$6.37
High
$6.37
Low
$6.02
Mkt. cap
1.06B
Avg. vol.
1.59M
Volume
1.94M
P/E ratio
111.07
52-wk high
$10.08
52-wk low
$4.30
EPS
$0.06
Beta
0.79
Shares outstanding
172.64M
No. of employees
435
News stories
From sources across the web
About Xeris Biopharma Holdings Inc
CEO-
Employees435
Founded2005
HeadquartersChicago, Illinois, United States
SectorPharmaceutical industry
Websitexerispharma.com
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.01 / -$0.00
+1,592.54%beat
Revenue / Est. (USD)
83.13M / 80.68M
+3.04%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
71.54M
74.38M
85.81M
83.13M
Cost of goods sold
11.90M
11.00M
10.95M
10.57M
Cost of revenue
11.90M
11.00M
10.95M
10.57M
Research and development expenses
8.06M
7.48M
7.87M
8.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44.39M
46.46M
47.50M
53.14M
Operating expense
55.16M
56.65M
58.09M
64.64M
Total operating expenses
67.06M
67.65M
69.03M
75.21M
Operating income
4.48M
6.73M
16.77M
7.92M
Other non operating income
-
-
-
-
EBT including unusual items
-1.93M
621.00K
11.08M
2.23M
EBT excluding unusual items
-1.93M
621.00K
11.08M
2.23M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.93M
621.00K
11.08M
2.23M
Net profit margin
-2.69%
0.83%
12.91%
2.69%
Earnings per share
-0.01
-
0.06
0.01
Interest and investment income
948.00K
1.16M
1.46M
1.20M
Interest expense
-7.36M
-7.27M
-7.15M
-6.88M
Net interest expenses
-6.41M
-6.11M
-5.69M
-5.68M
Depreciation and amortization charges
-
-
-
-
EBITDA
7.52M
9.78M
19.82M
10.96M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer